• Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jun. 91 p. [212 references]

Does not apply to this measure

This measure is used to assess the percentage of adult patients receiving heparin therapy for venous thromboembolism (VTE) who have a baseline platelet count before starting heparin, and then a platelet count every other day for at least the first 3 days of therapy.

The priority aim addressed by this measure is to reduce the risk of complications from anticoagulation therapy.

Venous thromboembolism (VTE); heparin therapy; platelet count

Total number of adult patients receiving heparin therapy for venous thromboembolism (VTE)

Total number of adult patients receiving heparin for venous thromboembolism (VTE) with a baseline platelet count and a platelet count obtained every other day for at least the first 3 days of therapy documented in the medical record

• A clinical practice guideline or other peer-reviewed synthesis of the clinical evidence

Unspecified

Current routine use

Internal quality improvement

Hospitals

Physicians

Group Clinical Practices

Age greater than or equal to 18 years

Either male or female

Unspecified

Unspecified

Unspecified

Unspecified

Unspecified

Unspecified

Getting Better

Effectiveness

Users of care only

Adults 18 years and older receiving heparin therapy for venous thromboembolism (VTE)

A list of all adult patients receiving heparin for VTE during the previous target period. The medical records can be reviewed to determine the documentation of a baseline platelet count and a platelet count obtained every other day for at least the first 3 days of therapy.

Data may be collected semiannually.

Patients associated with provider

Inclusions
Total number of adult patients receiving heparin therapy for venous thromboembolism (VTE)

Exclusions
Unspecified

All cases in the denominator are equally eligible to appear in the numerator

Clinical Condition
Therapeutic Intervention

Time window brackets index event

Inclusions
Total number of adult patients receiving heparin for venous thromboembolism (VTE) with a baseline platelet count and a platelet count obtained every other day for at least the first 3 days of therapy documented in the medical record

Exclusions
Unspecified

The measure results are somewhat or substantially under the control of the health care professionals, organizations and/or policymakers to whom the measure applies.

Fixed time period

Administrative data
Medical record

Individual Case

Unspecified

Rate

Better quality is associated with a higher score

Unspecified

Internal time comparison

Unspecified

Percentage of adult patients receiving heparin therapy for VTE who have a baseline platelet count before starting heparin, and then a platelet count every other day for at least the first 3 days of therapy.

Institute for Clinical Systems Improvement

The following Minnesota health plans provide direct financial support: Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, Metropolitan Health Plan, PreferredOne and UCare Minnesota. In-kind support is provided by the Institute for Clinical Systems Improvement's (ICSI) members.

Work Group Members: Bruce Burnett, MD (Work Group Leader) (Park Nicollet Health Services) (Internal Medicine); John Heit, MD (Mayo Clinic) (Hematology); Jeff Larsen, MD (River Falls Medical Clinic) (Internal Medicine); Denise Dupras, MD (Mayo Clinic) (Internal Medicine); Cindy Felty, NP (Mayo Clinic) (Nursing and Health Education); Peter Marshall, PharmD (HealthPartners Health Plan) (Pharmacy); Keith Harmon, MD (Park Nicollet Health Services) (Pulmonology); William Hagen, DO (Altru Health System) (Radiology); Mark Melin, MD (Park Nicollet Health Services) (Vascular Surgery); Amy Murphy, MHHA (Institute for Clinical Systems Improvement) (Measurement/Implementation Advisor); Sherri Huber, MT (ASCP) (Institute for Clinical Systems Improvement) (Facilitator)

Measure was not adapted from another source.

2006 Feb

2007 Jun

Please note: This measure has been updated. The National Quality Measures Clearinghouse is working to update this summary.

• Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jun. 91 p. [212 references]

This NQMC summary was completed by ECRI on May 1, 2006. This NQMC summary was updated by ECRI Institute on October 8, 2007.

This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions.

The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties.

If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc.

All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures.